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Abstract 
The Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) provided states with an 
optional Medicaid eligibility category for uninsured women with breast and/or cervical cancers.  The 
BCCPTA is the first and only such effort to use a population-based public health screening program, 
the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to provide a pathway to 
publicly funded health insurance for otherwise uninsured low-income women. Georgia was one of the 
first states to adopt the BCCPTA and was one of only twelve states that provided Medicaid eligibility to 
women screened by non-NBCCEDP providers. We use 2003 Georgia Medicaid claims and enrollment 
data to investigate the scope of the state’s BCCPTA enrollment and enrollees’ costs as well as 
demographic characteristics of breast and cervical cancer patients in Georgia’s BCCPTA and other 
Medicaid eligibility categories. Georgia’s Medicaid coverage of women with breast and/or cervical 
cancer under BCCPTA accounted for over one-third of all women with these cancers covered by the 
state in 2003 alone. Those newly eligible under BCCPTA were more likely to have breast, as opposed 
to cervical, cancer and to be older than those women with breast/cervical cancers enrolled in Georgia 
Medicaid due to low-income, pregnancy or disability status. Georgia’s Medicaid program spent over 
$29 million on BCCPTA enrollees in 2003 at a cost of over $12,000 per enrollee.  BCCPTA enrollee 
costs were more similar to those for disabled women with these cancers, about $19,500, than to 
costs for low-income/pregnant women which equaled about $7,500. By expanding Medicaid 
coverage, BCCPTA can potentially bring women in at earlier stages of their cancer and provide needed 
coverage/treatment.  Future research should examine the potential effect of BCCPTA on reduced 





The Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) in Georgia: 
Women Covered and Medicaid Costs in 2003 
 
On October 24, 2000, President Clinton 
signed the Breast and Cervical Cancer 
Prevention and Treatment Act (BCCPTA). The 
BCCPTA, enacted as Public Law 106-354, 
gave states the ability to establish a new 
optional Medicaid eligibility category for 
uninsured women under 65 who had been 
screened under the National Breast and 
Cervical Cancer Early Detection Program 
(NBCCEDP) and found to need treatment 
either for breast or cervical cancer or for a 
precancerous cervical condition. The 
NBCCEDP serves the uninsured with 
incomes below 250% of the federal poverty 
level (FPL). The first and only such effort to 
use a population-based public health 
screening program (NBCCEDP), BCCPTA was 
established as an effort to reduce the 
decades-old “treatment gap” for low-income 
women with no medical insurance by 
providing a pathway to publicly funded 
health insurance (Medicaid).  
     The BCCPTA has generated significant 
interest as a policy approach for addressing 
the challenges of the uninsured facing 
serious illness. Within a year of its passage, 
a majority of states had adopted the 
BCCPTA. Georgia adopted the BCCPTA 
pursuant to broad statutory authority by the 
Medicaid agency and began enrolling 
women in its BCCPTA program, the Women’s 
Health Medicaid Program (WHMP), on July 
1, 2001. From implementation through June 
2006, BCCPTA enrolled approximately 
4,800 women (Georgia Department of 
Community Health, 2006). Although BCCPTA 
mandated that women be screened by the 
NBCCEDP, states had options to also extend 
eligibility to women screened by non-
NBCCEDP providers. Georgia is one of 12 
states that selected this more expansive 
screening option. In 2005, only 25% of 
BCCPTA women were screened in health 
departments through Georgia’s NBCCEDP 
screening program (known as “Breast Test 
and More”); the majority (75%) was 
screened by private providers (Department 
of Community Health, 2006).  
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     Another distinction of BCCPTA from other 
Medicaid eligibility categories is that women 
are eligible for Medicaid only as long as they 
are “in treatment” for their cancers, but they 
can utilize any Medicaid covered service 
while eligible. If a BCCPTA woman is no 
longer in treatment at the time of 
recertification and if she is not eligible for 
Medicaid under other eligibility categories, 
she is disenrolled and usually referred back 
to her screening provider for follow-up care. 
The definition of “in treatment” is not 
explicit, however, and states differ in the 
timing and types of recertification required 
to confirm active cancer treatment. In order 
for BCCPTA women to get recertified in 
Georgia in 2003, they simply responded to 
Georgia’s Medicaid program by letter every 
six months indicating that they were still in 
active treatment. Since this time, Georgia’s 
Medicaid officials have considered a more 
formal process, whereby Breast Test and 
More staff could assist with the 
recertification process.  Given the unique 
collaboration of states’ screening programs 
and Medicaid agencies in determining 
eligibility, many NBCCEDP case managers 
assist women before, during, and after their 
treatment has ended. Although assisting 
with redetermination has become a logical 
role for these case managers, it is unclear 
what this change will mean for the 
percentage of women retaining coverage 
under BCCPTA eligibility.   
 
BCCPTA Study   
 
     Despite successful enrollment, little is 
known about how states’ adoption and 
implementation of the BCCPTA impacts low-
income, uninsured women with breast and 
cervical cancer, nor how much it expands 
pre-existing Medicaid coverage of women 
with cancer.  In 2004, Emory University 
received funding from the American Cancer 
Society (ACS) to examine the impact of 
BCCPTA in Georgia. This study uses 
quantitative data from Medicaid 
enrollment/claims and Georgia’s 
Comprehensive Cancer Registry (GCCR) data 
to assess if: 1) implementation of BCCPTA 
shortened the length of time between initial 
diagnosis and eventual enrollment into 
Medicaid; 2) women enrolling in Medicaid 
do so at earlier stages of cancer post 
BCCPTA and hence, with greater treatment 
options; and 3) significant variation (e.g., 
urban/rural) in treatment patterns exist. As 
a first step, we use 2003 Medicaid claims 
and enrollment data to ask: 
  
• What is the scope of BCCPTA enrollment 
and costs in Georgia’s Medicaid program? 
• How does this fit into Georgia’s overall 
coverage of women with breast or cervical 
cancer? 
• What are the demographic characteristics 
of women enrolled in the BCCPTA 
program, or in other Medicaid programs?  
 
     Assembling the claims/enrollment data is 
necessary to determine the 
procedure/diagnostic codes to identify 
women in Medicaid with evidence of breast 
and cervical cancers for our larger study.  
The resulting descriptive data are presented 
here to highlight the role that BCCPTA is 




     Women facing critical health challenges 
are in need of health insurance. If early 
symptoms or chronic diseases are not 
medically managed, uninsured women are 
more likely to experience poorer medical 
outcomes or to be diagnosed at later stages 
of life-threatening diseases such as cancer; 
in turn, they experience a greater risk of 
death from breast cancer (ACP, 2000; CDC, 
1998). The BCCPTA was developed to 
reduce both morbidity and mortality among 
women with such conditions. 
     Even prior to BCCPTA, Medicaid served 
as an important safety net for women with 
chronic health conditions and yet, there are 
relatively few studies specific to Medicaid 
enrollees with cancer (CDC, 1998).  One 
earlier study showed that the Medicaid 
insured presented with more advanced 
disease. Further, both Medicaid enrolled 
and uninsured women diagnosed with local 
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or regional stage disease had worse survival 
than privately-insured women, although 
there was no significant difference among 
women with distant metastases (Ayanian, 
Kohler, Abe, and Epstein, 1993). Another 
study found older, black women of lower 
socio-economic status treated in public 
hospitals (likely eligible for Medicaid) were 
more likely to have late stage breast or 
cervical cancer than younger, white, higher 
social class women treated in non-public 
hospitals (Mandleblatt, Andrews, Kerner, 
Zauber, and Burnett, 1991). 
     A study that linked Medicaid enrollment 
and Detroit cancer registry data found that 
Medicaid-insured women were more likely to 
have late-stage diagnosis, less likely to 
receive radiation if they had breast 
conserving surgery (BCS) and more likely to 
receive no surgery than other insured 
women (Bradley, Given, and Roberts, 2002). 
This linkage also provided new insight on 
racial disparities. Before controlling for 
Medicaid and area poverty, African-
American women had a higher likelihood of 
each unfavorable outcome but after 
controlling, African-American women only 
differed in treatment choice. They were less 
likely to have any surgery and if they did, it 
was more likely to be BCS (Bradley, 2002). 
Thus low socioeconomic status, as 
evidenced by Medicaid enrollment, was a 
better predictor than race of disease stage 
at diagnosis. 
      Another study used Medicaid claims 
data to identify incident cases in Ohio’s 
Medicaid population with registry data as 
the “gold standard” (Koroukian, Cooper, and 
Rim, 2003). The overall sensitivity was 
68.7%, but varied by sub-group and was as 
high as 78% for those enrolled all year. A 
linkage of Medicaid and California registry 
data found that of the 14,305 matched 
cases, 70% were not enrolled in Medi-Cal 
(California’s Medicaid program) either prior 
to or during the month of diagnosis (Perkins, 
Write, Allen, Samuels, and Romano, 2001). 
These authors concluded that despite 
difficulties in linking, such data can be used 
to assess access to care and cancer 
outcomes in this large, understudied and 
vulnerable population.  
  
DATA AND METHODS 
 
     While BCCPTA women can be identified 
based on eligibility codes, other women with 
breast or cervical cancer in Medicaid 
programs can only be identified using 
diagnosis/procedure codes found in claims. 
We use calendar year 2003 claims to 
identify all women with evidence of these 
cancers. We compiled lists of diagnosis and 
procedure codes (and NDC chemotherapy 
codes) from publications, consultation with 
Georgia Medicaid staff, and with our team’s 
clinical oncologist.  We cast a broad net to 
find women with breast or cervical cancers 
in Georgia Medicaid but were conservative 
when using procedure codes without a 
cancer diagnosis (during the year) since this 
could lead to over-identification of cancer 
cases. The list of codes employed to derive 
the samples is shown in Table 1.  
     We identified all unique women with at 
least one claim with any of these codes from 
inpatient, outpatient, drug, and long-term 
care claims. From this pool of women, we 
excluded: 1) women over 65; 2) women 
dually enrolled in Medicare; and 3) women 
in a nursing home during the year.  These 
exclusions were necessary since not all 
‘crossover’ claims - those involving both 
Medicare and Medicaid payments - nor long-
term care claims include all diagnostic, 
procedure, and payment detail. By making 
these exclusions, we identified a group of 
relatively younger women insured largely by 
Medicaid who were more comparable with 
those eligible for Medicaid through BCCPTA.  
     We then grouped women by the eligibility 
category on their first (cancer-related) claim 
during the year: 1) BCCPTA; 2) welfare or 
pregnancy-related; and 3) disabled women. 
Women with dependent children could 
qualify for Georgia Medicaid under welfare-
related criteria at approximately 33% of the 
Federal Poverty Level (FPL); FPL for a family 
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Table 1 
ICD-9 Breast and Cervix Cancer Diagnosis Codes, NDC Chemotherapy Codes, and CPT Breast and 
Cervix Procedure Codes 
  
Codes 
Breast Cancer Diagnosis ICD-9 Codes 233.0,174.0-174.9,238.3,239.3 
 
Cervix Cancer Diagnosis ICD-9 Codes 622.1,233.1,180.0-180.9 
  
Chemotherapy NDC Codes   54569-3765-00, 54569-8602-00, 00555-0446-
09, 00555-0446-63, 00555-0446-05, 00555-
0904-01, 00555-0904-14, 00555-0904-05, 
51552-0838-02, 63370-0251-10, 63370-0251-
15, 63370-0251-25, 63370-0251-35, 00172-
5656-49, 00172-5656-58, 00172-5656-70, 
00172-5656-80, 00172-5657-46, 00172-5657-
60, 00172-5657-70, 00172-5657-80, 38779-
0341-03, 38779-0341-01, 38779-0341-04, 
38779-0341-05, 62991-1151-02, 62991-1151-
01, 00378-0144-91, 00378-0274-93, 00378-
0274-01, 54868-3004-02, 54868-3004-01, 
00054-4831-21, 00054-8831-25, 00054-4831-
26, 00054-4834-13, 00054-4834-22, 00054-
8834-25, 49452-7571-05, 49452-7571-01, 
49452-7571-02, 49452-7571-06, 49452-7571-
03, 00093-0784-06, 00093-0784-86, 00093-
0782-56, 00093-0782-01 
 
Breast Procedure CPT Codes 19160; 19162; 19180; 19182; 19200; 19220; 
19240 
  
Cervix Procedure CPT Codes 57520; 57522 
 
2003). Pregnant women under 235% of the 
FPL would have qualified for Georgia 
Medicaid, and a woman with a disabling 
condition and on Supplemental Security 
Income (SSI), approximately 74% of the FPL, 




     The data in Table 2 show that, based on 
administrative files, a total of 2,379 women 
were enrolled in Georgia’s BCCPTA program 
at some point during 2003. These women 
were almost evenly split across the three 
non-teenage categories; roughly one-third 
were in each age group under 65.  Based on 
those with race/ethnic data (91% of total), 
the women enrolled in BCCPTA in 2003 
were predominantly white non-Hispanic 
(54%) with 32% categorized as non-Hispanic 
Black, 2% as Hispanic, and 2% as “other” 
ethnic groups.  Given the significant 
proportion of missing race data, it is likely 
that the percent Hispanic is 
underrepresented.  Survey data on families 
with children in Medicaid in 2003 indicate 
5% of the higher income, and 10% of the 
lower income families, were Hispanic 
(Ketsche, 2007).  BCCPTA women however, 
accounted for only 36% of the total 4,573 
identified by claims/codes (1,655 BCCPTA, 
1,887 welfare/pregnancy related and 1,031 
disabled). Based on the costs of those ever 
enrolled in BCCPTA, Medicaid spent $29 
million or about $12,400 per woman. The 
$27 million spent on BCCPTA enrollees with 
breast/cervical cancer claims represents 
44% of costs for women ($61.6 million)  
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Table 2 
Age, Race, Cost Breakdown for Women Ever Enrolled in BCCPTA, Women with Claims for Breast or Cervical 
Cancers and Eligible for BCCPTA on First Claim, Georgia Medicaid 2003 
  
All BCCPTA-Ever 
Enrolled in Year 
BCCPTA w/ 
Breast/Cervical 
Cancer Claims and 
BCCPTA Eligible at 
First Claim 
Women with Breast  
Cancer Claims and 
BCCPTA Eligible at First 
Claim  
Women with Cervical 
Cancer Claims and 
BCCPTA Eligible at 
First Claim 





% N=1,093 % N=595 % 
AGE                 
<20 33 1% 23 1% 0 0% 23 4% 
20-34 773 32% 335 20% 57 5% 284 48% 
35-49 773 32% 631 38% 451 41% 194 33% 
50-64 800 34% 666 40% 585 54% 94 16% 
RACE                 
Non-Hispanic White 1284 54% 809 49% 468 43% 355 60% 
Non-Hispanic Black 762 32% 586 35% 439 40% 158 27% 
Hispanic 59 2% 33 2% 16 1% 18 3% 
Other 49 2% 39 2% 30 3% 9 2% 
Missing 225 9% 188 11% 140 13% 55 9% 
COSTS                 
Total $29,409,475  100% $27,166,949  100% $22,171,588 100%  $ 5,857,984  100% 
Inpatient Services $5,469,035  19% $5,062,505  19% $3,439,421 16% $1,790,438 31% 
Outpatient Services $20,865,546  71% $19,346,937  71% $16,296,716 74% $3,682,447 63% 
Drug $3,074,894  10% $2,757,508  10% $2,435,452 11% $385,099 7% 
COSTS PER 
ENROLLEE                 
Total $12,362  100% $16,415  100% $20,285 100% $9,845 100% 
Inpatient Services $2,299  19% $3,059  19% $3,147 16% $3,009 31% 
Outpatient Services $8,771  71% $11,690  71% $14,910 74% $6,189 63% 
Drug $1,293  10% $1,666  10% $2,228 11% $647 7% 
 
identified by claims/codes. Both the BCCPTA 
and disabled eligibility category of women 
have costs that represent more of the total 
than they do of women covered because 
their per-person costs are significantly 
higher than those of low-income pregnant 
women.  Most of the latter group are 
experiencing cervical cancers and at a much 
lower cost per case.  
     For BCCPTA and other groups of 
enrollees outpatient services (e.g. physician 
and other ambulatory services such as 
laboratory, screening, etc) are more 
expensive in total and per person due 
largely to their greater volume. While 
inpatient services (e.g. hospital 
accommodations, surgical services, etc) are 
more costly per event there is a lower rate of 
usage per person.  
BCCPTA Eligible Women   
 
     We identified 1,655 unduplicated women 
with breast or cervical cancers with BCCPTA 
eligibility on their first cancer claim.  The 
difference between this and the 2,379 ever 
enrolled in BCCPTA during 2003 is 
comprised of: 1) 29 women who did not 
have BCCPTA on their first claim, but who 
were enrolled during the year, and 2) 695 
women in BCCPTA who either did not have a 
claim or had one outside of our identified 
diagnosis or procedure codes.  Some of the 
695 may have had precancerous cervical 
conditions (which qualify for BCCPTA). While 
we found such codes among their leading 
diagnoses, by and large, the leading 
diagnoses were not cancer-related. These 
695 women could also have had disease in 
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remission, but still considered “under 
treatment;” the great majority of them 
(almost 75%) either had no claim during the 
year (15%) or had at least one ‘case 
management’ claim/procedure (59%) listed 
by Georgia BCCPTA.  
     The split between breast and cervical 
cancer using the data based on claims is 
shown in Columns 2-3 in Table 2. Among the 
1,688 duplicated (33 had claims for both) 
BCCPTA women with either cancer, breast 
cases accounted for 65%. Total payments 
for BCCPTA women with claims for breast or 
cervical cancer were $27 million, equal to 
$16,415 per woman.  For breast cancer 
cases, total payments were $22 million, 
equal to $20,285 per woman. For cervical 
cancer cases, total payments were $5.8 
million, equal to $9,845 per woman.   
 
Welfare and Pregnancy Related Eligible 
Women 
 
     The Georgia Medicaid program serves 
many women with these and other cancers 
outside of BCCPTA.  As shown in Table 3, 
almost 1,900 women with either cancer and 
in either welfare or pregnancy-related 
eligibility categories received treatment in 
2003. (Data on the age/racial distributions 
should be compared with that in Columns 2-
3 in Table 2 which are also derived based 
on claims/codes). These data indicate that 
women with breast or cervical cancers in 
these eligibility groups are far more likely to 
be under age 35 (78% versus 33%) than 
BCCPTA enrollees and indeed, more likely to 
be teenagers (19% versus 1%). Even 
accounting for missing race, they are more 
likely to be non-Hispanic Blacks than are 
BCCPTA enrollees.    
     In contrast to BCCPTA, cervical cancer 
was far more common among Medicaid 
patients in the welfare or pregnancy 
categories (77% of these 1,895 duplicated 
cases). The costs per case among these 
younger women are lower at $7,548 overall 
(total payments were $14 million). For those 
with breast cancer, the average cost per 
case was $12,200 (total payments were $5 
million) while costs for cervical cancer cases 





     Georgia and other states’ Medicaid 
programs have historically served the low-
income with disabling conditions.  As shown 
in Table 4, a little over 1,000 women with 
evidence of breast or cervical cancers and 
disabled by these or other conditions were 
served in 2003.  As among BCCPTA women, 
the cases are predominately breast cancer 
(72%), and the costs per woman are similar 
at almost $20,000.  There are almost 300 
disabled women with evidence of cervical 
cancer, and these cases are just as costly as 
for BCCPTA women at $19,718. Women in 
this eligibility category are likely to be older 
than either BCCPTA women or women in the 
welfare and pregnancy related categories 
with approximately 59% between the ages 
of 50 and 64.  
 
CONCLUSIONS AND IMPLICATIONS 
 
     Prior to BCCPTA, many uninsured women 
with breast or cervical cancer qualified for 
Medicaid only when they were at late stages 
of disease and perhaps disabled by it 
(Ayanian et al., 1993).  The time between 
diagnosis and treatment was likely long for 
uninsured women who could not either 
afford treatment or find doctors willing to 
provide charity care. The BCCPTA created a 
potentially new and quicker pathway into 
Medicaid. The data shown here indicate that 
BCCPTA women with breast cancer are more 
like the Medicaid disabled than those 
eligible through other avenues, in terms of 
age and costs, but are still younger and 
somewhat less expensive to serve. BCCPTA 
women with cervical cancers are certainly 
younger than the disabled women, and they 
have markedly lower costs.  This may reflect 
detection/treatment at earlier stages of 
disease or a lack of co-morbidities among 
BCCPTA women compared with those the 
disabled possess.  
     When BCCPTA was created, there was 
little information for state policy makers  
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Table 3 
Age, Race, Cost Breakdown for Women with Claims for Breast or Cervical Cancers and Enrolled in 
Welfare or Pregnancy-Related Category on First Claim, Georgia Medicaid 2003 
  
Women with  Breast 
or Cervical Cancer 
Claims and Welfare 
or Pregnancy-
Related Eligibility at 
First Claim  
Women with Breast 
Cancer Claims and 
Welfare or Pregnancy-
Related Eligibility at First 
Claim  
Women with Cervical 
Cancer Claims and 
Welfare or Pregnancy-







% N=440 % N=1455 % 
AGE             
<20 352 19% 47 11% 305 21% 
20-34 1118 59% 138 31% 982 67% 
35-49 363 19% 206 47% 163 11% 
50-64 54 3% 49 11% 5 0% 
RACE             
Non-Hispanic White 811 43% 147 33% 669 46% 
Non-Hispanic Black 1051 56% 280 64% 774 53% 
Hispanic 3 0% 1 0% 2 0% 
Other 11 1% 4 1% 7 0% 
Missing 11 1% 8 2% 3 0% 
COSTS             
Total $14,243,272 100% $5,368,003 100% $9,070,747 100% 
Inpatient Services $3,399,623 24% $1,271,492 24% $2,225,033 25% 
Outpatient Services $9,414,445 66% $3,492,421 65% $6,013,085 66% 
Drug $1,429,204 10% $604,089 11% $832,629 9% 
COSTS PER ENROLLEE             
Total $7,548 100% $12,200 100% $6,234 100% 
Inpatient Services $1,802 24% $2,890 24% $1,529 25% 
Outpatient Services $4,989 66% $7,937 65% $4,133 66% 
Drug $757 10% $1,373 11% $572 9% 
 
regarding the costs that Medicaid would 
face since data on the costs of cancer 
treatment are often limited. Many states 
made estimates of anticipated BCCPTA 
costs but these have not been made 
available to researchers. In a study based 
on the Medical Expenditure Panel Survey 
(MEPS), Medicaid insured (age <65) had 
expenses close (93%) to those of the 
privately insured, but both had much higher 
expenses than the uninsured (Thorpe and 
Howard, 2003). The uninsured were also 
found to have lower provider encounters 
and fewer hospital admissions, perhaps 
indicative of less cancer care. On an 
annualized basis, the expenses for the 
Medicaid insured were $15,610 (Thorpe 
and Howard, 2003), lower but still quite 
consistent with the dollar amounts reported 
here for Georgia Medicaid women with 
breast cancer.  
     While BCCPTA women accounted for over 
one-third of the women under age 65 served 
by Georgia’s Medicaid program in 2003 (the 
second year of BCCPTA), it is important to 
note the role Medicaid coverage plays 
independent of BCCPTA. Georgia Medicaid 
insured almost 2,000 younger women with 
breast and especially, cervical cancers 
among women in their pregnancy or welfare 
eligibility groups. That these young women 
end up using Medicaid for these diagnoses 
relates in part to screening for cervical 
cancer at younger ages than other cancers 
and that many women who are single heads 
of households and/or young married  
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Table 4:  
Age, Race, Cost Breakdown for Women with Claims for Breast or Cervical Cancers and Enrolled in Disability 
Category on First Claim, Georgia Medicaid 2003 
  
Women with Breast or Cervical 
Cancer Claims and Disability 
Eligibility at First Claim 
Women with  Breast Cancer 
Claims and Disability 
Eligibility at First Claim 
Women with  Cervical 
Cancer Claims and 






% N = 749 % N=293 % 
AGE             
<20 13 1% 3 0% 10 3% 
20-34 98 10% 26 3% 73 25% 
35-49 316 31% 215 29% 106 36% 
50-64 604 59% 505 67% 104 35% 
RACE            
Non-Hispanic White 356 35% 251 34% 109 37% 
Non-Hispanic Black 497 48% 361 48% 142 48% 
Hispanic 7 1% 6 1% 1 0% 
Other 9 1% 6 1% 3 1% 
Missing 162 16% 125 17% 38 13% 
COSTS            
Total $20,210,958 100% $14,862,105 100% $5,777,233 100% 
Inpatient Services $5,540,801 27% $3,739,745 25% $1,918,383 33% 
Outpatient Services $11,054,919 55% $8,392,379 56% $2,884,074 50% 
Drug $3,615,238 18% $2,729,981 18% $974,776 17% 
COSTS PER ENROLLEE            
Total $19,603 100% $19,843 100% $19,718 100% 
Inpatient Services $5,374 27% $4,993 25% $6,547 33% 
Outpatient Services $10,723 55% $11,205 56% $9,843 50% 
Drug $3,507 18% $3,645 18% $3,327 17% 
 
mothers are likely to lack private insurance 
coverage (Guyer, Broaddus, and Dude, 
2001). Given high cure rates for cervical 
cancer with early detection/treatment, both 
traditional Medicaid eligibility and the 
expansion through BCCPTA can serve as a 
critical safety net and perhaps help reduce 
morbidity and mortality related to this 
preventable cancer.    
     The NBCCEDP has just been reauthorized 
through fiscal year 2011. While funding has 
increased, it still falls far below that needed 
to cover all uninsured women for free or 
subsidized screens.  If uninsured women 
still get screened and if screening leads to a 
cancer diagnosis, BCCPTA can provide 
needed coverage/treatment.  Georgia’s 
experience shows that 75% of the otherwise 
BCCPTA-eligible women received screening 
privately. If this experience can be 
generalized to other states, it is important 
that they consider expanding BCCPTA to 
women screened by any provider. Future 
research should examine the role of BCCPTA 
in bringing women into Medicaid at earlier 
stages and potentially, reducing morbidity 
and mortality as it was intended to do.  
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